Entospletinib,Lanraplenib
Kronos Bio,gilead
[]
"#pressrelease: kronos bio continues to advance investigational syk inhibitors entospletinib and lanraplenib with new preclinical data at eha2022 congress #news": 
Flying the web for trusted world news reports and shopping discounts 24/7. Retweeting for opinions, useful information, and the many voices of Twitter.